USA Today reports that study subjects lost dramatic amounts of weight with diabetes drug tirzepatide. Participants in the randomized, controlled trial lost an average of 15% of their weight at week 72 according to an article in the New England Journal of Medicine . Photo by Sara Bakhshi on Unsplash How does it work? USA Today's interview with a participant offers a clue: The drug prevented her from overeating, [participant Mary] Bruehl said. If she overindulged, the food would come back up. "I've learned to stop before I get that feeling," she said...The one negative side effect was nausea, which Bruehl felt the day after each of her weekly shots of tirzepatide. She's not alone. From the study , The most common adverse events with tirzepatide were gastrointestinal, and most were mild to moderate in severity, occurring primarily during dose escalation. Adverse events caused treatment discontinuation in 4.3%, 7.1%, 6.2%, and 2.6% of participants receiving ...
Do-it-yourself health. Low-carb, mostly evolutionary.